Mục tiêu của nghiên cứu: Mô tả chi phí điều trị trực tiếp do biến chứng HKTM 90 ngày sau phẫu thuật, thông qua cơ sở dữ liệu bồi hoàn bảo hiểm y tế quốc gia. | Chi phí điều trị trực tiếp do biến chứng huyết khối tĩnh mạch 90 ngày sau phẫu thuật VNU Journal of Science: Medical and Pharmaceutical Sciences, Vol. 35, No. 2 (2019) 105-111 Original Article Direct costs for treatment of venous thromboembolism complication 90-day after surgery Bui My Hanh1,2,*, Duong Tuan Duc3, Tran Tien Hung3, Nguyen Huu Chinh4, Kieu Thi Tuyet Mai5 1 HaNoi Medical University, No 1, Ton That Tung, Dong Da, Hanoi, Vietnam 2 Ha Noi Medical University Hospital, No 1, Ton That Tung, Dong Da, Hanoi, Vietnam 3 Viet Nam Social Security, No 150, Pho Vong street, Thanh Xuan, Hanoi, Vietnam 4 Nation Institute of Nutrition, No 2, Yersin, Hai Ba Trung, Hanoi, Vietnam 5 Hanoi University of Pharmacy, No 15, Le Thanh Tong, Hoan Kiem, Hanoi, Vietnam Received 31 July 2019 Revised 07 August 2019; Accepted 14 August 2019 Abstract: Study object: Describe the direct treatment costs due to venous thromboembolism complications 90 days after surgery by using national health insurance reimbursement database. Patients: 824,947 adult patients who underwent major surgeries were enrolled from January 1, 2017 to September 31, 2018. Method: Study was conducted by using cross-sectional descriptive design. Patients were considered VTE case if they had a diagnostic code up to 90 days after the first surgery, thus 1472 were diagnosed as having VTE after surgery. The study using propensity score matching method shows that there were 913 pairs of patients with the same propensity score included in analysis. Results: The rate of hospital re-admission and outpatient visit were and in group of VTE patient after matching, respectively. The mean 90-day postoperative cost in VTE group after matching was found to be ± thousand VNĐ, which is times higher than the expenditure of non-VTE group with ± thousand VNĐ. Conclusion: The costs related to VTE treatment can be used to
